Decay-accelerating factor modulates induction of T cell immunity

被引:238
作者
Heeger, PS
Lalli, PN
Lin, F
Valujskikh, A
Liu, JB
Muqim, N
Xu, YY
Medof, ME
机构
[1] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[3] Univ Alabama, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
关键词
D O I
10.1084/jem.20041967
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Decay-accelerating factor (Daf) dissociates C3/C5 convertases that assemble on host cells and thereby prevents complement activation on their surfaces. We demonstrate that during primary T cell activation, the absence of Daf on antigen-presenting cells (APCs) and on T cells enhances T cell proliferation and augments the induced frequency of effector cells. The effect is factor D- and, at least in part, C5-dependent, indicating that local alternative pathway activation is essential. We show that cognate T cell-APC interactions are accompanied by rapid production of alternative pathway components and down-regulation of Daf expression. The findings argue that local alternative pathway activation and surface Daf protein function respectively as a costimulator and a negative modulator of T cell immunity and explain previously reported observations linking complement to T cell function. The results could have broad therapeutic implications for disorders in which T cell immunity is important.
引用
收藏
页码:1523 / 1530
页数:8
相关论文
共 28 条
[1]  
ARVIEUX J, 1988, IMMUNOLOGY, V65, P229
[2]   Influence of C3 deficiency on atherosclerosis [J].
Buono, C ;
Come, CE ;
Witztum, JL ;
Maguire, GF ;
Connelly, PW ;
Carroll, M ;
Lichtman, AH .
CIRCULATION, 2002, 105 (25) :3025-3031
[3]   Noncovalent associations of T lymphocyte surface proteins [J].
Cerny, J ;
Stockinger, H ;
Horejsi, V .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) :2335-2343
[4]  
DAVIS LS, 1988, J IMMUNOL, V141, P2246
[5]   In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen) [J].
Goldberg, J ;
Shrikant, P ;
Mescher, MF .
JOURNAL OF IMMUNOLOGY, 2003, 170 (01) :228-235
[6]   The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF) [J].
Hamann, J ;
Vogel, B ;
vanSchijndel, GMW ;
vanLier, RAW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1185-1189
[7]   CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts [J].
He, CS ;
Heeger, PS .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) :698-704
[8]   Effects of T cell frequency and graft size on transplant outcome in mice [J].
He, CS ;
Schenk, S ;
Zhang, QW ;
Valujskikh, A ;
Bayer, J ;
Fairchild, RL ;
Heeger, PS .
JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :240-247
[9]   GPI-microdomains:: a role in signalling via immunoreceptors [J].
Horejsi, V ;
Drbal, K ;
Cebecauer, M ;
Cerny, J ;
Brdicka, T ;
Angelisová, P ;
Stockinger, H .
IMMUNOLOGY TODAY, 1999, 20 (08) :356-361
[10]  
JANEWAY C, 2004, IMMUNOBIOLOGY, P37